FMP
Harmony Biosciences Holdings, Inc.
HRMY
NASDAQ
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
32.72 USD
0 (0%)
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
3.22B
3.08B
3.34B
3.8B
4.13B
4.41B
4.7B
5.02B
5.35B
5.71B
212.7M
245M
369.7M
252.2M
256.3M
339.29M
361.95M
386.12M
411.91M
439.41M
-167.6M
-104.5M
-94M
-150.3M
-184.9M
-174.99M
-186.68M
-199.14M
-212.44M
-226.63M
45.1M
140.5M
275.7M
101.9M
71.4M
164.3M
175.27M
186.98M
199.46M
212.79M
5.59
5.59
5.59
5.59
5.59
155.6M
157.21M
158.83M
160.47M
162.12M
794.24M